78
Participants
Start Date
April 30, 2006
Primary Completion Date
January 31, 2012
Study Completion Date
January 31, 2012
Long-acting somatostatin
Patients randomized to treatment will be given intramuscularly long-acting somatostatin (Sandostatin-LAR, Novartis, Basel) at the dose of 40 mg every 28 days (in two intragluteal 20 mg injections).
Saline solution
Patients randomized to placebo will be given intramuscularly the same volume of solvent used to dissolve somatostatin every 28 days (in two intragluteal injections).
"Hospital Ospedali Riuniti Unit of Nephrology and Dialysis", Bergamo
"University Federico II of Naples", Napoli
Hospital Cà Foncello, Treviso
"Hospital V. Fazzi - Unit of neprology and Dialysis", Lecce
"Hospital Presidio Osp. Maggiore Policlinico", Milan
Mario Negri Institute for Pharmacological Research
OTHER